| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/01/2006 | CN1726937A Yuganning capsule |
| 02/01/2006 | CN1726935A Medication for treating gastric disease |
| 02/01/2006 | CN1726922A Usage of stigmastane-3,5,6-alcohol and derivative for preparing antiviral remedy, and new stigmastane-3,5,6-derivative of tri-alcohol |
| 02/01/2006 | CN1726921A Oral preparation of prostaglandin E1 |
| 02/01/2006 | CN1726920A Nose taking powder of prostaglandin E |
| 02/01/2006 | CN1240259C Method for forming holes, using flexible connection board formed thereof and its producing method |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239482C Positive modulators for nicotinic receptor agonists |
| 02/01/2006 | CN1239478C 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 02/01/2006 | CN1239199C Medicine for treating gastritis and peptic ulcer |
| 02/01/2006 | CN1239192C Chinese medicine composition for treating fang deficiency of epigastric pain and preparing method thereof |
| 02/01/2006 | CN1239187C Chinese medicine composition for curing chronic atrophic sastritis and its preparing method and quality control method |
| 02/01/2006 | CN1239184C Chinese medicinal composition for treating 'epigastalgia' deficiency of yin syndrome and its preparation method |
| 02/01/2006 | CN1239183C A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof |
| 02/01/2006 | CN1239171C Traditional Chinese medicine composition for treating hepatic disease |
| 02/01/2006 | CN1239168C Medicine for treating constipation and preparation method thereof |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 02/01/2006 | CN1239154C 5-HT IA receptor subtype agonist |
| 01/31/2006 | US6992211 Crystalline form of phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 01/31/2006 | US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 01/31/2006 | US6992086 Antagonists of MCP-1 function and methods of use thereof |
| 01/31/2006 | US6992074 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 01/31/2006 | US6992068 Brazilian licorice extract and periandrins, which are constituents thereof, have an anti inflammatory effect and an immunosuppressive effect |
| 01/31/2006 | US6992067 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 01/31/2006 | US6991929 Hepatitis A vaccines |
| 01/31/2006 | US6991817 Acid-modified arabinogalactan protein composition |
| 01/31/2006 | US6991815 compositions which are effective in preventing and/or treating peptic ulcer diseases, comprising an effective amount of American ginseng and/or its extract |
| 01/31/2006 | US6991620 Apparatus for delivery of therapeutic and/or diagnostic agents |
| 01/31/2006 | US6991619 Apparatus for delivery of therapeutic and/or diagnostic agents |
| 01/31/2006 | CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/31/2006 | CA2259345C Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents |
| 01/31/2006 | CA2208839C Quinuclidine derivatives and medicinal composition thereof |
| 01/26/2006 | WO2006009764A1 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 01/26/2006 | WO2006009645A1 Methods of using macrocyclic modulators of the ghrelin receptor |
| 01/26/2006 | WO2006009291A1 Method of inducing the differentiation of mesenchymal stem cell into odontoblast cell |
| 01/26/2006 | WO2006009114A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020046 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 01/26/2006 | US20060020041 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019886 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 01/26/2006 | US20060019884 Peptide composition |
| 01/26/2006 | US20060019882 Use of Yops as caspase inhibitor |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060018920 Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
| 01/26/2006 | US20060018903 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | CA2579726A1 Macrocyclic modulators of the ghrelin receptor |
| 01/26/2006 | CA2573674A1 Muscarinic antagonists with parp and sir modulating activity as agents for inflammatory diseases |
| 01/26/2006 | CA2573673A1 Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
| 01/26/2006 | CA2572793A1 Progression inhibitor for disease attributed to abnormal accumulation of liver fat |
| 01/26/2006 | CA2571237A1 Methods of using macrocyclic modulators of the ghrelin receptor |
| 01/26/2006 | CA2570800A1 Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1619207A2 HLA-A2.1 binding peptides derived from HCV and their uses |
| 01/25/2006 | EP1619194A2 Triazaspiro[5.5]undecane derivatives and pharmaceutical composition comprising the same as active ingredient |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1618883A1 Agent for preventing and ameliorating constipation |
| 01/25/2006 | EP1618086A2 Compounds for the treatment of metabolic disorders |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1617853A1 Isolation of the hepatoprotective agent acteoside from colerbrokea oppositifolia |
| 01/25/2006 | EP1617846A1 The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
| 01/25/2006 | EP1617842A1 Oral pharmaceutical formulations comprising acid-labile active ingredients and a water-soluble sugar derivate, use thereof and the suitable process for manufacturing these |
| 01/25/2006 | EP1617839A1 The use of azetidinecarboxamide derivatives in therapy |
| 01/25/2006 | EP1506179B1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 01/25/2006 | EP1393066A4 Insulin producing cells derived from human embryonic stem cells |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP0987022B1 Conagenin for the treatment of ulcerous colitis and/or crohn's disease |
| 01/25/2006 | CN1726214A Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 01/25/2006 | CN1726049A Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 01/25/2006 | CN1726048A Gastric acid secretion inhibiting composition |
| 01/25/2006 | CN1726023A Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
| 01/25/2006 | CN1726022A Pregabalin derivatives for the treatment of fibromyalgia and other disorders and its derivitive |
| 01/25/2006 | CN1726021A Alpha2delta ligands for the treatment of sexual dysfunction |
| 01/25/2006 | CN1726015A Alpha2delta ligands for different pharmaceutical uses |
| 01/25/2006 | CN1724549A Nucleoside phosphonate compound |
| 01/25/2006 | CN1724533A Method of extracting deydrokaividing and solubilizing injection agent from rock gold thread total alkaloid |
| 01/25/2006 | CN1724527A Application of fraxiketone as medicine for treating liver disease |
| 01/25/2006 | CN1724071A Novel use of cell wall skeleton of red nocar-ray-fungus for treating liver diseases |
| 01/25/2006 | CN1724059A Traditional Chinese medicinal prepn. for treating biailary calculi |
| 01/25/2006 | CN1724053A Traditional Chinese medicinal composition for reinforcing body fluid, tonifying spleen, dredging deposit and lowering qi, and prepn. method and application thereof |
| 01/25/2006 | CN1724052A External application medicine for treating appendicitis, and its prepn. method |
| 01/25/2006 | CN1724048A Anti-senility oral liquor |
| 01/25/2006 | CN1724045A Traditional Chinese medicinal prepn. for reinforcing kidney and strengthening body |
| 01/25/2006 | CN1724044A Compound medicinal prepn. for treating colitis |
| 01/25/2006 | CN1724037A Traditional Chinese medicinal oral liquor for treating liver trouble |
| 01/25/2006 | CN1724033A Health-care food having functions of retarding-senility and regulating-immunity, and its prepn. method |
| 01/25/2006 | CN1724030A Traditional Chinese medicinal prepn. for treating constipation of slow-remove type, and its prepn. method |
| 01/25/2006 | CN1724029A Health-care medicated wines with reinforcing-kidney and nourishing yin and strong then yang function, and its prepn. method |